Patrick C. Machado's most recent trade in Alumis Inc. was a trade of 15,528 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 30, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alumis Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 15,528 | 15,528 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 3,553 | 3,553 | - | 0 | Common Stock | |
| Arcus Biosciences Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2026 | 16,900 | 16,900 | - | - | Stock Option (Right to Buy) | |
| Arcus Biosciences Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2026 | 5,700 | 44,300 (0%) | 0% | 0 | Common Stock | |
| Xenon Pharma Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2026 | 10,507 | 10,507 | - | - | Share Option (Right to Buy) | |
| Xenon Pharma Inc | Patrick C. Machado | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2026 | 2,645 | 2,645 (0%) | 0% | - | Common Shares | |
| Xenon Pharma Inc | Patrick C. Machado | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2026 | 2,645 | 0 | - | - | Restricted Share Units | |
| Xenon Pharma Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2026 | 1,593 | 1,593 | - | - | Restricted Share Units | |
| Alumis Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2025 | 49,800 | 49,800 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 10,450 | 10,450 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 3,140 | 3,140 | - | - | Stock Option (Right to Buy) | |
| Arcus Biosciences Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 38,300 | 38,300 | - | - | Stock Option (Right to Buy) | |
| Arcus Biosciences Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 13,300 | 38,600 (0%) | 0% | 0 | Common Stock | |
| Xenon Pharma Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 17,012 | 17,012 | - | - | Share Option (Right to Buy) | |
| Xenon Pharma Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 2,645 | 2,645 | - | - | Restricted Share Units | |
| Alumis Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 44,364 | 44,364 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 41,499 | 41,499 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 19,528 | 19,528 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 13,804 | 13,804 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 11,189 | 11,189 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 7,064 | 7,064 | - | - | Common Stock | |
| Alumis Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc | Patrick C. Machado | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 38,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 10,520 | 10,520 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 3,300 | 3,300 | - | - | Stock Option (Right to Buy) | |
| Acelyrin Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 92,158 | 92,158 | - | - | Director Stock Option (right to buy) | |
| Arcus Biosciences Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Arcus Biosciences Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 8,400 | 25,300 (0%) | 0% | 0 | Common Stock | |
| Xenon Pharma Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 15,542 | 15,542 | - | - | Stock Option (Right to Buy) | |
| Acelyrin Inc | Patrick C. Machado | Director | Other type of transaction at price $ 0.00 per share. | 04 Oct 2023 | 14,675 | 14,675 | - | 0 | Common Stock | |
| Arcus Biosciences Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 19,500 | 19,500 | - | - | Stock Option (Right to Buy) | |
| Arcus Biosciences Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 6,800 | 16,900 (0%) | 0% | 0 | Common Stock | |
| Chimerix Inc | Patrick C. Machado | Director | 09 Jun 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | ||
| Adverum biotech Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 12,500 | 52,500 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharma Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 18,475 | 18,475 | - | - | Stock Option (Right to Buy) | |
| Acelyrin Inc | Patrick C. Machado | Director | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 86,206 | 86,206 | - | - | Director Stock Option (right to buy) | |
| Acelyrin Inc | Patrick C. Machado | Director | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 86,206 | 0 | - | - | Director Stock Option (right to buy) | |
| Acelyrin Inc | Patrick C. Machado | Director | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 40,567 | 40,567 | - | - | Director Stock Option (right to buy) | |
| Acelyrin Inc | Patrick C. Machado | Director | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 40,567 | 0 | - | - | Director Stock Option (right to buy) | |
| Acelyrin Inc | Patrick C. Machado | Director | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 28,675 | 0 | - | - | Director Stock Option (right to buy) | |
| Acelyrin Inc | Patrick C. Machado | Director | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 28,675 | 28,675 | - | - | Director Stock Option (right to buy) | |
| Acelyrin Inc | Patrick C. Machado | Director | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 23,243 | 23,243 | - | - | Director Stock Option (right to buy) | |
| Acelyrin Inc | Patrick C. Machado | Director | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 23,243 | 0 | - | - | Director Stock Option (right to buy) | |
| Acelyrin Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 23,243 | 23,243 | - | - | Director Stock Option (right to buy) | |
| Xenon Pharma Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2022 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Chimerix Inc | Patrick C. Machado | Director | 23 Jun 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | ||
| Arcus Biosciences Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 16,800 | 16,800 | - | - | Stock Option (Right to Buy) | |
| Arcus Biosciences Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 4,100 | 10,100 (0%) | 0% | 0 | Common Stock | |
| Adverum biotech Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Adverum biotech Inc | Patrick C. Machado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) |